New research, published in the Milbank Quarterly, highlights the potential health and economic impact of the United States (US) Food and Drug Administration's (FDA) proposed voluntary salt policy on workers in the US food ...
Jul 24, 2019
0
1
(HealthDay)—A staging system of β-amyloid (Aβ) accumulation may be useful for monitoring patients throughout the course of Alzheimer disease (AD), according to a study published online July 17 in JAMA Neurology to coincide ...
Jul 18, 2019
0
3
The maker of OxyContin has been cast as the chief villain in the nation's opioid crisis. But newly released government figures suggest Purdue Pharma had plenty of help in flooding the U.S. with billions of pills even as overdose ...
Jul 17, 2019
0
6
(HealthDay)—A plan to let Medicare patients receive rebates that drug companies currently pay to insurers and middlemen has been withdrawn by the Trump administration.
Jul 12, 2019
0
0
State and local governments suing over the toll of a nationwide opioid crisis agree that companies in the drug industry should be held accountable, but they have differences on who should have the power to strike any settlement, ...
Jun 25, 2019
0
1
From 2012 to 2016 the drug industry donated over £57 million to UK patient organisations, with priority given to a small number of organisations supporting commercially high profile conditions like cancer, reveals an analysis ...
May 22, 2019
0
2
Withdrawal symptoms following the practice of discontinuation, or abruptly "coming off," of psychiatric drugs in randomized clinical trials may be mistaken for relapse and bolster the case for continued use of medication, ...
Apr 22, 2019
0
15
After repeated food poisoning outbreaks tied to romaine lettuce, a U.S. food safety official shared his concerns in an internal email, saying the produce industry's water testing "failed in an epic and tragic way."
Mar 29, 2019
1
4
The company that has made billions selling the prescription painkiller OxyContin says it is considering bankruptcy as one of several possible legal options.
Mar 13, 2019
0
0
Paying for cancer drugs based on how well they work in practice could help patients get new treatments faster, according to a Cancer Research UK report published today.
Feb 21, 2019
0
0
